Investors – Race Oncology

Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

ASX Announcements

Reports

Title	Link
Annual Report 2022	Download
Race Oncology - Pitt Street Research Initiation Report - October 2022	Download
Bisantrene Combo Poster	Download
The Rediscovery of Bisantrene: A Review of the Literature	Download

Presentations

Title	Link
Race Oncology AGM 2022 Presentation	Download
Race Oncology AGM 2021 Presentation	Download
Race Oncology AGM 2020 Presentation	Download

Corporate Governance

Title	Link
Corporate Governance Plan	Download
Corporate Governance Statement	Download
Board of Directors' Skills Matrix	Download
Replacement Constitution	Download

Share Price

Latest News

December 2022 Update

Posted on 14 December 2022 by Daniel Tillett / 0 comments

Race is pleased to announce the appointment of global pharmaceutical and commercial leader, Mr Damia…

Race Submits Human Ethics Application to Commence Cardioprotection Breast Cancer Trial

Posted on 9 December 2022 by Daniel Tillett / 0 comments

Danny Sharp appointed an Independent Non-Executive Director of Race

Posted on 5 December 2022 by Daniel Tillett / 0 comments

Race Oncology 2022 AGM Presentation

Posted on 29 November 2022 by Daniel Tillett / 0 comments

Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett.

Race Receives Positive Guidance on Zantrene via Pre-IND Meeting with US FDA

Posted on 23 November 2022 by Daniel Tillett / 0 comments

Race Oncology

Targeting Zantrene® towards better cancer outcomes

Contact Us